Translating findings from basic research into clinical application
The NeuroCure Clinical Research Center (NCRC) was established in July 2008 as the clinical research center of NeuroCure within the Charité – Universitätsmedizin Berlin. It creates the structural conditions for the efficient implementation of clinical studies and forms the heart of the Cluster.
The NCRC provides all NeuroCure/neuroscientific researchers with supportive services for planning and conducting their own investigator-initiated trials (IITs) and studies in cooperation with industry.
New findings from basic neuroscientific research - for example on stroke, multiple sclerosis, dementia, epilepsy or psychiatric disorders - can be tested in clinical studies and subsequently implemented in diagnostics and therapy. Patients have direct access to the new diagnosis and therapy methods via study participation.
In the future, the NCRC will be extended by the NCRC BrainLab module. In close cooperation with other clinical areas such as the rescue centre, neurosurgery, or intensive care unit, treatment methods, especially for acute and hyperacute diseases, will be developed.
Since 2014, the NCRC has been certified as a Clinical Research Center that includes Site Management Organisation and Biomarker Sample Management for developing, conducting and administering neurological and psychiatric studies according to DIN ISO 9001.
The NCRC is currently establishing a Neuroscience Clinical Research Unit (Neuroscience CRU) within the Clinical Study Center (CSC) together with the neurological and psychiatric units of the Berlin Institute of Health (BIH) CRU.